CLINICAL TRIALS PROFILE FOR LABETALOL HYDROCHLORIDE
⮫ Send this page by email
✉ Email this page to a colleague
« Back to Dashboard
All Clinical Trials for LABETALOL HYDROCHLORIDE
Trial ID
Title
Status
Sponsor
Phase
Start Date
Summary
NCT00000291 ↗ Effects of Labetalol on Human Cocaine Use - 8
Completed
University of Minnesota
Phase 2
1997-10-01
The purpose of this study is to determine the effect of labetalol treatment on the subjective
and physiological effects of cocaine.
NCT00000291 ↗ Effects of Labetalol on Human Cocaine Use - 8
Completed
University of Minnesota - Clinical and Translational Science Institute
Phase 2
1997-10-01
The purpose of this study is to determine the effect of labetalol treatment on the subjective
and physiological effects of cocaine.
NCT00000291 ↗ Effects of Labetalol on Human Cocaine Use - 8
Completed
National Institute on Drug Abuse (NIDA)
Phase 2
1997-10-01
The purpose of this study is to determine the effect of labetalol treatment on the subjective
and physiological effects of cocaine.
NCT00000297 ↗ Effects of Labetalol on Nicotine Administration in Humans - 14
Completed
University of Minnesota
Phase 2
1998-10-01
The purpose of this study is to investigate the effects of labetalol in response to
intravenous nicotine
NCT00000297 ↗ Effects of Labetalol on Nicotine Administration in Humans - 14
Completed
University of Minnesota - Clinical and Translational Science Institute
Phase 2
1998-10-01
The purpose of this study is to investigate the effects of labetalol in response to
intravenous nicotine
NCT00000297 ↗ Effects of Labetalol on Nicotine Administration in Humans - 14
Completed
National Institute on Drug Abuse (NIDA)
Phase 2
1998-10-01
The purpose of this study is to investigate the effects of labetalol in response to
intravenous nicotine
>Trial ID
>Title
>Status
>Phase
>Start Date
>Summary
Clinical Trial Conditions for LABETALOL HYDROCHLORIDE
Condition Name
Condition Name for LABETALOL HYDROCHLORIDE
Intervention
Trials
Hypertension in Pregnancy
7
Hypertension
6
Preeclampsia
6
Pre-Eclampsia
3
[disabled in preview]
0
Subscribe for full access, or try a Trial
Condition MeSH
Condition MeSH for LABETALOL HYDROCHLORIDE
Intervention
Trials
Hypertension
23
Pre-Eclampsia
21
Hypertension, Pregnancy-Induced
16
Eclampsia
8
[disabled in preview]
0
Subscribe for full access, or try a Trial
Clinical Trial Locations for LABETALOL HYDROCHLORIDE
Trials by Country
Trials by Country for LABETALOL HYDROCHLORIDE
Location
Trials
United States
40
Egypt
11
Canada
7
Pakistan
2
Saudi Arabia
2
Subscribe for full access, or try a Trial
Trials by US State
Trials by US State for LABETALOL HYDROCHLORIDE
Location
Trials
New York
11
Ohio
4
California
4
Tennessee
3
Texas
3
Subscribe for full access, or try a Trial
Clinical Trial Progress for LABETALOL HYDROCHLORIDE
Clinical Trial Phase
Clinical Trial Phase for LABETALOL HYDROCHLORIDE
Clinical Trial Phase
Trials
Phase 4
24
Phase 3
6
Phase 2/Phase 3
2
[disabled in preview]
33
Subscribe for full access, or try a Trial
Clinical Trial Status
Clinical Trial Status for LABETALOL HYDROCHLORIDE
Clinical Trial Phase
Trials
Completed
28
Recruiting
13
Unknown status
8
[disabled in preview]
14
Subscribe for full access, or try a Trial
Clinical Trial Sponsors for LABETALOL HYDROCHLORIDE
Sponsor Name
Sponsor Name for LABETALOL HYDROCHLORIDE
Sponsor
Trials
Weill Medical College of Cornell University
3
University of Alberta
3
Mansoura University
3
[disabled in preview]
8
Subscribe for full access, or try a Trial
Sponsor Type
Sponsor Type for LABETALOL HYDROCHLORIDE
Sponsor
Trials
Other
83
NIH
4
U.S. Fed
4
[disabled in preview]
3
Subscribe for full access, or try a Trial
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
